Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients-Reference-Cited by-同舟云学术

Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients

Published:2013-11-15 Issue:1 Volume:92 Page:19-25
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Lund Johan¹,Uttervall Katarina¹,Liwing Johan¹,Gahrton Gösta¹,Alici Evren¹,Aschan Johan¹,Holmberg Erik²,Nahi Hareth¹

Affiliation:

1. Department of Medicine; Karolinska Institutet; Stockholm Sweden

2. Department of Oncology; Institute of Clinical Sciences; Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12213/fullpdf

Reference15 articles.

1. Is multiple myeloma a chronic disease? A population based study comparing 1843 patients to a matched Swedish population;Nahi;Blood,2012

2. Clinical course of patients with relapsed multiple myeloma;Kumar;Mayo Clin Proc,2004

3. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma;Davies;Blood,2001

4. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

5. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens;Alexanian;JAMA,1969

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry ( MRDR );British Journal of Haematology;2022-07-11

2. Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013;PLOS ONE;2018-12-05

3. Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma;Cancer Medicine;2018-04-19

4. Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT;Bone Marrow Transplantation;2015-04-13